Related Experiment Video
Updated: Aug 5, 2026

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts
Published on: May 16, 2021
A reproducible computational transcriptomic framework for cell-type-resolved fibroinflammatory-AKT remodeling in
1Department of Cardiovascular Medicine, Liyang People's Hospital, Liyang, Changzhou, Jiangsu Province 213300, PR China; Jiangnan University, Wuxi, Jiangsu, China.
This study links human heart failure (HF) gene signatures to specific cell types and identifies potential drug targets. It provides a computational framework for understanding HF at a cellular and molecular level.
Area of Science:
- Cardiovascular Biology
- Computational Biology
- Genomics
Background:
- Human heart failure (HF) involves complex transcriptional changes across multiple cell types.
- Existing transcriptomic studies often lack cell-type specificity and direct links to potential interventions.
- Bridging this gap is crucial for a deeper understanding of HF pathogenesis.
Purpose of the Study:
- To develop a computational framework for integrating diverse transcriptomic data in human heart failure.
- To identify cell-type-specific transcriptional remodeling in HF.
- To prioritize potential therapeutic targets through perturbational analysis.
Main Methods:
- Integrated human left-ventricular bulk transcriptomes with single-cell/single-nucleus atlas data.
- Utilized external single-nucleus RNA sequencing (snRNA-seq) for validation.
- Applied module scoring, ligand-receptor analysis, and LINCS/L1000 perturbational matching.
Main Results:
- Identified 14,358 HF-associated genes, with 1633 consistently upregulated and 785 downregulated.
- Localized significant remodeling to cardiomyocytes, fibroblasts, and myeloid cells.
- Revealed a fibroinflammatory axis involving activated fibroblasts and inflammatory myeloid cells, linked to AKT signaling.
Conclusions:
- Established a computational framework connecting reproducible HF signatures with cell-type resolution.
- Provided a method for prioritizing perturbational genomic targets in HF research.
- Highlighted glimepiride and simvastatin as candidates for further experimental validation.
More Related Videos
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018